Gerardo Gamba Selected Research

Gerardo Gamba Research Topics

Disease

45	Hypertension (High Blood Pressure) 11/2023 - 01/2002
13	Pseudohypoaldosteronism 01/2022 - 01/2003
12	Hyperkalemia 11/2022 - 01/2003
11	Acute Kidney Injury (Acute Renal Failure) 03/2022 - 07/2007
11	Ischemia 01/2021 - 07/2007
6	Fibrosis (Cirrhosis) 01/2021 - 01/2003
6	Acidosis 01/2021 - 01/2003
5	Chronic Renal Insufficiency 01/2023 - 01/2013
5	Inflammation (Inflammations) 01/2021 - 11/2014
4	Bartter Syndrome (Syndrome, Bartter) 05/2009 - 09/2004
3	Hypotension (Low Blood Pressure) 05/2015 - 04/2004
3	Reperfusion Injury 02/2014 - 07/2007
2	Inborn Genetic Diseases (Disease, Hereditary) 10/2023 - 01/2016
2	Hypokalemia 11/2022 - 05/2015
2	Heart Failure 01/2021 - 11/2013
2	Obesity 01/2020 - 01/2018
2	Insulin Resistance 01/2020 - 01/2018
2	Body Weight (Weight, Body) 01/2018 - 11/2015
2	Hypertrophy 01/2018 - 01/2017
2	Hypercalciuria 01/2018 - 02/2005
2	Proteinuria 01/2017 - 01/2005
2	Alkalosis 11/2014 - 06/2014
2	Osteoporosis 04/2013 - 09/2007
2	Neoplasms (Cancer) 04/2013 - 01/2013
2	Hypovolemia 09/2012 - 03/2009
1	Hypercalcemia (Milk Alkali Syndrome) 01/2023
1	Edema (Dropsy) 01/2023
1	Glycosuria 01/2023
1	COVID-19 10/2022
1	Endotoxemia 01/2020
1	Lupus Nephritis 01/2019
1	Segmental glomerulosclerosis 01/2019
1	Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis 01/2019
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 01/2018
1	Weight Gain 01/2018
1	Pancreatic Neoplasms (Pancreatic Cancer) 11/2016
1	Schizophrenia (Dementia Praecox) 06/2016

Drug/Important Bio-Agent (IBA)

15	Phosphotransferases (Kinase)IBA 10/2018 - 02/2005
14	SaltsIBA 01/2023 - 04/2004
9	Lysine (L-Lysine)FDA Link 12/2020 - 01/2003
8	Member 3 Solute Carrier Family 12IBA 01/2022 - 01/2003
8	salicylhydroxamic acid (SHAM)IBA 01/2021 - 07/2007
8	Spironolactone (Aldactone)FDA LinkGeneric 01/2019 - 01/2003
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2005
7	Messenger RNA (mRNA)IBA 11/2016 - 01/2005
6	ThiazidesIBA 11/2023 - 09/2004
6	Mineralocorticoid Receptors (Mineralocorticoid Receptor)IBA 01/2019 - 07/2007
6	AldosteroneIBA 01/2018 - 10/2009
5	ChloridesIBA 10/2023 - 06/2008
5	PotassiumIBA 01/2022 - 02/2005
5	Protein Serine-Threonine Kinases (Protein-Serine-Threonine Kinase)IBA 06/2008 - 01/2003
4	DiureticsIBA 11/2023 - 09/2004
4	Cyclosporine (Ciclosporin)FDA LinkGeneric 01/2023 - 07/2007
4	thiazide receptorIBA 01/2022 - 04/2004
4	Protein Kinases (Protein Kinase)IBA 01/2020 - 02/2005
4	Angiotensin IIIBA 01/2018 - 03/2009
3	CationsIBA 10/2023 - 02/2006
3	Glucose (Dextrose)FDA LinkGeneric 01/2023 - 01/2018
3	Biomarkers (Surrogate Marker)IBA 01/2023 - 01/2011
3	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2015 - 01/2011
3	CollagenIBA 01/2013 - 01/2003
2	UbiquitinIBA 10/2023 - 11/2014
2	Tacrolimus (Prograf)FDA LinkGeneric 01/2023 - 11/2015
2	Sodium Chloride Symporter Inhibitors (Diuretics, Thiazide)IBA 01/2023 - 09/2007
2	FructoseIBA 01/2023 - 01/2023
2	Cullin Proteins (Cullins)IBA 01/2021 - 11/2014
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 01/2017
2	Ammonium Chloride (Sal Ammoniac)FDA Link 01/2021 - 11/2013
2	CytokinesIBA 10/2020 - 01/2013
2	ElectrolytesIBA 01/2016 - 02/2005
2	Fibronectins (Fibronectin)IBA 01/2013 - 01/2003
2	K Cl- CotransportersIBA 09/2008 - 01/2004
2	Member 1 Solute Carrier Family 12IBA 06/2008 - 05/2006
2	Sodium Potassium Chloride Symporter Inhibitors (Loop Diuretics)IBA 06/2008 - 05/2006
2	Antihypertensive Agents (Antihypertensives)IBA 01/2008 - 09/2007
2	CreatinineIBA 01/2007 - 01/2005
2	Transforming Growth Factor beta (TGF-beta)IBA 01/2007 - 01/2003
1	Ligases (Synthetase)IBA 10/2023
1	dapagliflozinIBA 01/2023
1	CalciumIBA 01/2023
1	FructosuriaIBA 01/2023
1	Sodium Chloride SymportersIBA 11/2022
1	VaccinesIBA 10/2022
1	Proline (L-Proline)FDA Link 01/2022
1	Phenobarbital (Luminal)FDA Link 01/2022
1	Fibroblast Growth Factors (Fibroblast Growth Factor)IBA 10/2021
1	Prorenin ReceptorIBA 01/2021
1	GenisteinIBA 01/2020
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2020
1	Endothelin B ReceptorIBA 01/2019
1	Nitric Oxide Synthase Type III (Endothelial Nitric Oxide Synthase)IBA 01/2019
1	alpha 1-Antichymotrypsin (alpha 1 Antichymotrypsin)IBA 01/2019
1	Calcium-Sensing ReceptorsIBA 01/2018
1	Hormones (Hormone)IBA 01/2018
1	Epithelial Sodium ChannelsIBA 01/2018
1	GeraniinIBA 01/2018
1	Alanine (L-Alanine)FDA Link 01/2018

Therapy/Procedure

1	Liver Transplantation 03/2022
1	Nephrectomy 01/2021
1	Therapeutics 10/2016